| Kelley Renee' Yarbrough-yale, DNP, APRN, ACCNS-AG | |
|
1500 S Main St, Fort Worth, TX 76104-4917 | |
| (817) 702-8144 | |
| Not Available |
| Full Name | Kelley Renee' Yarbrough-yale |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Acute Care |
| Location | 1500 S Main St, Fort Worth, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538944830 | NPI | - | NPPES |
| 22200425 | Other | CERTIFIED DIABETES CARE & EDUCATION SPECIALIST (CDCES) |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2100X | Clinical Nurse Specialist - Acute Care | AP135676 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelley Renee' Yarbrough-yale, DNP, APRN, ACCNS-AG 7825 Arnold Ter, North Richland Hills, TX 76180-7307 Ph: (817) 368-5565 | Kelley Renee' Yarbrough-yale, DNP, APRN, ACCNS-AG 1500 S Main St, Fort Worth, TX 76104-4917 Ph: (817) 702-8144 |
News Archive
Covaris Inc. today announced that it has signed a co-marketing agreement with Illumina, Inc. making Covaris DNA shearing technologies the recommended method of shearing with Illumina next-generation sequencing product lines, including HiSeq, HiScanSQ, and Genome Analyzer.
Pathway Therapeutics, Inc., a company developing novel therapeutics that target the PI3K and mTOR pathways, today announced that the FDA has accepted an IND filing for PWT33597, which allows Pathway to commence Phase 1 clinical testing.
Pfizer Inc. today announced that data from a Phase 2 efficacy and safety study of tasocitinib the company's investigational oral JAK inhibitor, met its primary endpoint of a statistically significant greater proportion of patients achieving at least a 75 percent reduction from baseline in PASI (Psoriasis Area and Severity Index) at week 12 in individuals with chronic moderate to severe plaque psoriasis.
As is well-known, Congress has a constitutional duty to examine presidential nominees like Dr. Berwick. But apparently, the prospect of giving the American people an opportunity to hear this nominee defend his past praise for government-run systems that ration healthcare was worrisome enough for the administration that it sought to ignore congressional oversight altogether (Sen. Mitch McConnell, 7/12).
A drug designed to tackle diabetes could also be repurposed as the first treatment to prevent miscarriage by targeting the lining of the womb itself, according to a clinical trial led by the University of Warwick.
› Verified 9 days ago
Dr. Nicole Lea Frederick, DNP, APRN,ACCNS-AG Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 2001 Thistle Park Dr Apt 5105, Fort Worth, TX 76110 Phone: 817-907-6953 | |
Allison Sweeney Snyder, CNS Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1301 Pennsylvania Ave, Fort Worth, TX 76104 Phone: 817-250-6350 | |
Randall Matthew Mccoy, MSN, RN, CNS-AG Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1400 8th Ave, Fort Worth, TX 76104 Phone: 817-926-2544 | |
Lori Jean Muhr Iii, DNP, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1500 S Main St, Fort Worth, TX 76104 Phone: 817-702-2975 | |
Katie Elaine Malone, DNP, AGCNS-BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1325 Pennsylvania Ave Ste 500, Fort Worth, TX 76104 Phone: 817-250-2000 | |
Charlyn Pafford Wagley, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1301 Pennsylvania Ave, Fort Worth, TX 76104 Phone: 817-250-3907 | |
Cynthia Luisa Almanza, PA-C Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1401 W Pulaski St, Fort Worth, TX 76104 Phone: 682-885-8012 Fax: 682-885-8014 |